# US 2002/0055185 A1 · Complex chemical compound, synthesis and various applications of said compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0055185 A1
- Document ID: US20020055185A1
- Status: Published application
- Kind: A1
- Application number: 09/485,154
- Filed: 2000-02-04
- Published: 2002-05-09
- Earliest claimed: 1997-08-07
- Inventors: CLAIRE MINARD; CAROLE CHAIX; THIERRY DELAIR; BERNARD MANDRAND
- Web page: https://patentgrep.com/patent/US20020055185A1

## CPC

- C40B 50/14: Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
- A61K 47/58: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C08F 8/00: Chemical modification by after-treatment (graft polymers, block polymers, crosslinking with unsaturated monomers or with polymers C08F251/00 - C08F299/00; of conjugated diene rubbers C08C)
- C07B 2200/11: Compounds covalently bound to a solid support
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The invention concerns a complex chemical compound comprising a solid carrier and at least a conjugate consisting of an organic polymer and a plurality of priming biomers. The invention also concerns the synthesis of said chemical compound for biopolymer synthesis and the use of said complex chemical compound after synthesis as ligand for amplifying or detecting and/or capturing target molecules.

## Claims

### Claim 1

Complex chemical compound comprising:
a solid support,
surface chemical groups linked to the solid support via covalent bonding,
a conjugate comprising an organic polymer comprising chemical side functions linked to the surface groups, and chemical side residues
characterized in that starting biomonomers, which are optionally chemically modified, are linked covalently, on the one hand to the chemical residues of said organic polymer, respectively, and on the other hand each to a biopolymer.

### Claim 2 (depends on 1)

Compound according to claim 1, characterized in that the covalent bonding of the starting biomonomers to the chemical residues of the organic polymer cannot be cleaved under the conditions for cleaving the support/organic polymer bond.

### Claim 3 (depends on 1)

Compound according to claim 1, characterized in that the side functions of the reactive organic polymer are of electrophilic and/or thiol and/or disulfide bridge type.

### Claim 4 (depends on 1)

Chemical compound according to claim 1, characterized in that the starting biomonomers, which may be identical or different, are nucleosides and/or nucleotides and/or amino acids and/or saccharides, which may be natural or modified.

### Claim 5 (depends on 4)

Compound according to claim 4, characterized in that the starting biomonomers are both nucleotides and amino acids.

### Claim 6 (depends on 1)

Compound according to claim 1, characterized in that the starting biomonomers are extended and polymerized with other synthons, each according to a predetermined sequence of said synthons, in order to obtain mixed biopolymers, such as oligonucleotides and/or peptides linked to the organic polymer.

### Claim 7 (depends on 6)

Chemical compound according to claim 6, characterized in that the mixed biopolymers are of oligonucleotide and peptide or oligonucleotide-peptide type.

### Claim 8 (depends on 7)

Complex chemical compound according to claim 7, characterized in that the biopolymers fort, with the organic polymer to which they are linked, ligands which can be linked directly or indirectly to anti-ligands.

### Claim 9 (depends on 1)

Process for the chemical synthesis of a compound according to claim 1, comprising the following steps:
a) a functional solid support comprising surface groups is provided;
b) at least one reactive organic polymer is provided, the backbone of which comprises, on the one hand, chemical side functions complementary to the surface groups of the solid support, and, on the other hand, chemical side residues;
c) starting biomonomers, which may be identical or different, for biopolymerization are provided, comprising, on the one hand, a reactive substituent, and, on the other hand, a protective group;
d) at least said organic polymer is reacted:
either with the solid support, to establish a covalent bond between the surface groups of said solid support and the side functions of said organic polymer, after which the organic polymer linked to the solid support is reacted with the starting biomonomers, to graft these biomonomers covalently, directly Or indirectly, with the side residues of said organic polymer;
or with the starting biomonomers, to graft these biomonomers covalently, directly or indirectly, with the side residues of said organic polymer, after which the organic polymer linked to the starting biomonomers is reacted with the solid support, to establish a covalent bond between the surface groups of said solid support and the side functions of said organic polymer.

### Claim 10 (depends on 9)

Process according to claim 9, characterized in that it comprises, after step c and before step d, the following step:
c′) the organic polymer is reacted with a reagent which generates spacer arms, to graft spacer arms onto the side functions of said organic polymer, respectively, each spacer arm comprising a reactive function at its free end.

### Claim 11

Complex chemical compound comprising:
a solid support,
surface chemical groups linked to the solid support via covalent bonding,
at least one conjugate comprising an organic polymer comprising chemical side functions linked to the surface groups, and chemical side residues,
characterized in that starting biomonomers, i.e. chemically modified biomonomers, are linked covalently to the chemical residues of said organic polymer, respectively.

### Claim 12 (depends on 11)

Use of the compound according to claim 11, to carry out the synthesis of a ligand, comprising the steps in which:
f) identical or different synthons are provided,
g) the biopolymer chains are grown from starting biomonomers of the compound, respectively, by successive cycles of coupling/deprotection, according to at least one same predetermined sequence of synthons,
h) the support/organic polymer bond is cleaved.

### Claim 13 (depends on 12)

Use according to claim 12, comprising, between steps g and h, the step in which:
i) biopolymer chains are grown from other starting biomonomers, respectively, by successive cycles of coupling/deprotection of the synthons, according to at least one same other predetermined sequence of synthons.

### Claim 14 (depends on 12)

Use according to claim 12, characterized in that step (h) is carried out by chemical or enzymatic or thermal or photochemical reaction.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

Reagent, characterized in that it comprises a chemical compound according to any one of claims 1 to 11.
